Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats

作者: Tsukasa Nozu , Saori Miyagishi , Shima Kumei , Rintaro Nozu , Kaoru Takakusaki

DOI: 10.1016/J.EJPHAR.2017.10.056

关键词:

摘要: Abstract Statins have been reported to block inflammatory somatic pain and an anti-cytokine property. Lipopolysaccharide (LPS) or repeated water avoidance stress (WAS) induces visceral hypersensitivity increases gut permeability in rats, which are mediated through proinflammatory cytokine-dependent pathways. Since with increased plays a crucial role the pathophysiology of irritable bowel syndrome (IBS), these above animal models considered simulate IBS. We hypothesized that lovastatin improves symptoms patients IBS by attenuating changes. The threshold visceromotor response (VMR) induced colonic balloon distention was measured for assessment sensation rats. Colonic determined vivo quantifying absorbed Evans blue tissue 15 min using spectrophotometer. Subcutaneously (s.c.) injected LPS (1 mg/kg) reduced VMR after 3 h. Pretreatment (20 mg/kg s.c. daily 3 days) abolished this LPS. Repeated WAS (1 h allodynia, also blocked injection before each session. antinociceptive effect on LPS-induced allodynia reversed mevalonolactone, N G -nitro-L-arginine methyl ester naloxone. Lovastatin LPS- WAS-induced permeability. These results indicate possibility can be useful treating

参考文章(47)
Ikuo Inoue, Sei-ichi Goto, Kasumi Mizotani, Takuya Awata, Toshiyuki Mastunaga, Shin-ichiro Kawai, Takanori Nakajima, Shigeru Hokari, Tugikazu Komoda, Shigehiro Katayama, Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect Life Sciences. ,vol. 67, pp. 863- 876 ,(2000) , 10.1016/S0024-3205(00)00680-9
Ulrich Laufs, Beyond lipid-lowering: effects of statins on endothelial nitric oxide. European Journal of Clinical Pharmacology. ,vol. 58, pp. 719- 731 ,(2003) , 10.1007/S00228-002-0556-0
M. Ortiz Lucas, P. Saz Peiró, J. J. Sebastián Domingo, Hipótesis inmune del síndrome del intestino irritable: Segunda parte: papel de las citokinas Revista Espanola De Enfermedades Digestivas. ,vol. 102, pp. 711- 717 ,(2010) , 10.4321/S1130-01082010001200006
A. Dlugosz, P. Nowak, M. D'Amato, G. Mohammadian Kermani, J. Nyström, S. Abdurahman, G. Lindberg, Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterology and Motility. ,vol. 27, pp. 1747- 1754 ,(2015) , 10.1111/NMO.12670
Mónica Ortego, Carmen Bustos, Miguel A Hernández-Presa, José Tuñón, Cristina Dı́az, Gonzalo Hernández, Jesús Egido, Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells Atherosclerosis. ,vol. 147, pp. 253- 261 ,(1999) , 10.1016/S0021-9150(99)00193-8
Takuya Suzuki, Naho Yoshinaga, Soichi Tanabe, Interleukin-6 (IL-6) Regulates Claudin-2 Expression and Tight Junction Permeability in Intestinal Epithelium Journal of Biological Chemistry. ,vol. 286, pp. 31263- 31271 ,(2011) , 10.1074/JBC.M111.238147
Mahesh M. Ghaisas, Prasad R. Dandawate, Suyash A. Zawar, Yogesh S. Ahire, Santosh P. Gandhi, Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models Inflammopharmacology. ,vol. 18, pp. 169- 177 ,(2010) , 10.1007/S10787-010-0044-6
Yvette Taché, Cornelia Kiank, Andreas Stengel, A role for corticotropin-releasing factor in functional gastrointestinal disorders. Current Gastroenterology Reports. ,vol. 11, pp. 270- 277 ,(2009) , 10.1007/S11894-009-0040-4